Ana M. Ortega‐Villa
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Colorectal Cancer Screening and Detection, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Colorectal Cancer Surgical Treatments, Gut microbiota and health
Most-Cited Works
- → Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States(2019)113 cited
- → Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial(2021)63 cited
- → Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial(2023)62 cited
- → Characteristics and outcome of facial nerve palsy from Lyme neuroborreliosis in the United States(2022)36 cited
- → Reappraisal of Idiopathic CD4 Lymphocytopenia at 30 Years(2023)33 cited
- → Severe Mycobacterial Immune Reconstitution Inflammatory Syndrome (IRIS) in Advanced Human Immunodeficiency Virus (HIV) Has Features of Hemophagocytic Lymphohistiocytosis and Requires Prolonged Immune Suppression(2022)30 cited
- → Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial(2023)23 cited
- → Assessment of Osteoporosis and Fracture Risk in Mastocytosis within a North American Cohort(2021)19 cited
- → Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine(2024)17 cited
- → Maternal stress and neonatal anthropometry: the NICHD Fetal Growth Studies(2017)17 cited